Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relationship between carbamoyl-phosphate synthetase genotype and systemic vascular function.

Marshall L Summar1, James V Gainer, Mias Pretorius

  • 1Department of Pediatrics, Division of Medical Genetics, Vanderbilt University Medical Center, Nashville, Tenn 37232-6602, USA.

Hypertension (Dallas, Tex. : 1979)
|January 14, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional, molecular, and digital measurements of biological age.

The Journal of clinical investigation·2026
Same author

A tribute to Eugene Braunwald (1929-2026).

The Journal of clinical investigation·2026
Same author

Supply and Demand in the Mathematics of Rare Disease Drug Development: Why Choosing the Right Model Is Crucial.

Clinical and translational science·2026
Same author

The Placebo Effect in Rare Disease Clinical Trials: Measurement, Impact, and Statistical Approaches for Patient-as-Own-Control Designs.

Clinical and translational science·2026
Same author

Erythroid-produced intact FGF23 is a paracrine inhibitor of erythropoiesis.

Blood·2026
Same author

Metabolic Vulnerability Index and Risk of Total Mortality: Findings From the Multi-Ethnic Study of Atherosclerosis.

Circulation. Population health and outcomes·2026

A genetic variation in carbamoyl-phosphate synthetase 1 influences nitric oxide (NO) levels and NO-mediated vasodilation in humans. This finding highlights the role of genetic factors in regulating NO production and vascular function.

Area of Science:

  • Biochemistry
  • Genetics
  • Physiology

Background:

  • Endothelial cells synthesize l-arginine, the precursor to nitric oxide (NO), from l-citrulline.
  • Carbamoyl-phosphate synthetase 1 (CPS1) catalyzes the rate-limiting step in l-citrulline formation.
  • A specific nucleotide transversion (T1405N) in the CPS1 gene has been identified.

Purpose of the Study:

  • To investigate the impact of a CPS1 gene polymorphism (T1405N) on NO metabolite concentrations in humans.
  • To assess the influence of the CPS1 genotype on NO-mediated vasodilation.
  • To determine the relationship between CPS1 genotype and vascular smooth muscle reactivity.

Main Methods:

  • Healthy subjects (n=106) underwent brachial artery infusions of bradykinin at varying doses.

Related Experiment Videos

  • Forearm blood flow was measured using plethysmography.
  • Blood samples were analyzed for NO metabolites and cyclic GMP; sodium nitroprusside infusions were also performed in a subset of subjects (n=87).

    • Main Results:

    • A significant association was found between CPS1 genotype and NO metabolite concentrations, with the highest levels in CC homozygotes and lowest in AA homozygotes.
    • CPS1 genotype significantly affected forearm blood flow during bradykinin infusion, with the greatest vasodilation observed in CC homozygotes.
    • Vascular responses to sodium nitroprusside also varied significantly by CPS1 genotype, indicating an effect on vascular smooth muscle reactivity.

    Conclusions:

    • A polymorphism in the CPS1 gene influences nitric oxide production in humans.
    • The CPS1 genotype affects NO-mediated vasodilation and vascular smooth muscle responses.
    • These findings underscore the genetic regulation of NO homeostasis and vascular function.